# The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients.

> **NCT01675453** · PHASE2 · COMPLETED · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 40 (actual)

## Conditions studied

- Coronary Artery Disease
- Edema

## Interventions

- **DRUG:** 7.2% NaCl plus 6% hydroxyethyl starch 200/0.5
- **DRUG:** 0.9% NaCl

## Key facts

- **NCT ID:** NCT01675453
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-09
- **Final completion:** 2012-09
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2016-05-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01675453

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01675453, "The Efficacy and Safety of Hypertonic Saline in Cardiac Surgery Patients.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01675453. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*